Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009
- PMID: 22544199
- PMCID: PMC3572869
- DOI: 10.1093/cid/cir1017
Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009
Abstract
Surveillance of human immunodeficiency virus type 1 transmitted drug resistance (TDR) was conducted among pregnant women in South Africa over a 5-year period after the initiation of a large national antiretroviral treatment program. Analysis of TDR data from 9 surveys conducted between 2005 and 2009 in 2 provinces of South Africa suggests that while TDR remains low (<5%) in Gauteng Province, it may be increasing in KwaZulu-Natal, with the most recent survey showing moderate (5%-15%) levels of resistance to the nonnucleoside reverse transcriptase inhibitor drug class.
References
-
- World Health Organization. WHO progress report, 2010. Available at: http://www.who.int/hiv/pub/2010progressreport/ch4_en.pdf. Accessed 15 July 2011.
-
- National HIV and syphilis antenatal sero-prevalence survey in South Africa. Pretoria, South Africa: Epidemiology and Surveillance Directorate, Department of Health; 2005. Department of Health.
-
- National HIV and syphilis antenatal sero-prevalence survey in South Africa. Pretoria, South Africa: Epidemiology and Surveillance Directorate, Department of Health; 2009. Department of Health.
-
- Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organization’s global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 2008;13(Suppl 2):1–13. - PubMed
-
- Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther. 2008;13(Suppl 2):25–36. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases